Sanara MedTech (SMTI) Competitors $29.38 -0.58 (-1.94%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$29.58 +0.20 (+0.66%) As of 04/15/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. AORT, ESTA, EYE, AXGN, EMBC, BVS, RXST, CBLL, IRMD, and AVNSShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include Artivion (AORT), Establishment Labs (ESTA), National Vision (EYE), AxoGen (AXGN), Embecta (EMBC), Bioventus (BVS), RxSight (RXST), CeriBell (CBLL), Iradimed (IRMD), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Artivion Establishment Labs National Vision AxoGen Embecta Bioventus RxSight CeriBell Iradimed Avanos Medical Sanara MedTech (NASDAQ:SMTI) and Artivion (NYSE:AORT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, community ranking, institutional ownership and earnings. Does the media prefer SMTI or AORT? In the previous week, Artivion had 1 more articles in the media than Sanara MedTech. MarketBeat recorded 3 mentions for Artivion and 2 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 0.96 beat Artivion's score of 0.71 indicating that Sanara MedTech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanara MedTech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Artivion 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate SMTI or AORT? Sanara MedTech presently has a consensus target price of $48.50, indicating a potential upside of 65.08%. Artivion has a consensus target price of $31.40, indicating a potential upside of 36.43%. Given Sanara MedTech's higher possible upside, equities research analysts clearly believe Sanara MedTech is more favorable than Artivion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Artivion 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, SMTI or AORT? Sanara MedTech has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500. Comparatively, Artivion has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Is SMTI or AORT more profitable? Artivion has a net margin of -0.22% compared to Sanara MedTech's net margin of -10.71%. Artivion's return on equity of 5.15% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% Artivion -0.22%5.15%1.91% Do insiders and institutionals hold more shares of SMTI or AORT? 8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 86.4% of Artivion shares are owned by institutional investors. 54.1% of Sanara MedTech shares are owned by insiders. Comparatively, 8.1% of Artivion shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has better earnings and valuation, SMTI or AORT? Sanara MedTech has higher earnings, but lower revenue than Artivion. Artivion is trading at a lower price-to-earnings ratio than Sanara MedTech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M3.02-$4.30M-$1.14-25.77Artivion$388.54M2.53-$30.69M-$0.31-74.24 Does the MarketBeat Community prefer SMTI or AORT? Artivion received 4 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 81.82% of users gave Artivion an outperform vote while only 60.53% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes2360.53% Underperform Votes1539.47% ArtivionOutperform Votes2781.82% Underperform Votes618.18% SummaryArtivion beats Sanara MedTech on 11 of the 17 factors compared between the two stocks. Remove Ads Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$261.54M$8.61B$5.33B$7.57BDividend YieldN/A1.71%5.11%4.32%P/E Ratio-29.6818.5321.7317.81Price / Sales3.0270.45379.2094.61Price / CashN/A19.6738.1534.64Price / Book5.634.856.464.00Net Income-$4.30M$284.66M$3.20B$247.23M7 Day Performance0.62%0.22%2.85%1.45%1 Month Performance-9.29%-1.67%-8.55%-6.24%1 Year Performance-7.17%-21.42%10.46%0.60% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech1.9944 of 5 stars$29.38-1.9%$48.50+65.1%-8.9%$261.54M$86.67M-29.6860Gap DownAORTArtivion2.7599 of 5 stars$23.05-0.7%$31.40+36.2%+13.1%$969.16M$388.54M-1,152.451,300News CoveragePositive NewsGap DownHigh Trading VolumeESTAEstablishment Labs2.1802 of 5 stars$31.30-3.1%$57.40+83.4%-38.3%$902.88M$166.03M-12.13960Analyst ForecastNews CoverageGap DownHigh Trading VolumeEYENational Vision2.0503 of 5 stars$11.35+0.4%$14.00+23.3%-39.3%$894.19M$1.82B-56.7514,000Positive NewsGap DownAXGNAxoGen2.9597 of 5 stars$16.62+2.5%$22.60+36.0%+122.6%$737.00M$187.34M-51.94450Short Interest ↑News CoveragePositive NewsGap DownEMBCEmbecta4.5228 of 5 stars$12.09+0.8%$23.00+90.2%+12.5%$702.84M$1.11B12.091,900Gap DownHigh Trading VolumeBVSBioventus3.1717 of 5 stars$8.27-0.7%$15.00+81.4%+67.2%$677.68M$573.28M-13.561,200News CoveragePositive NewsGap DownRXSTRxSight3.0248 of 5 stars$16.61+2.2%$43.78+163.6%-72.5%$672.56M$139.93M-20.01220Analyst ForecastGap DownHigh Trading VolumeCBLLCeriBellN/A$18.19-1.4%$32.50+78.7%N/A$652.44M$65.44M0.00N/ANews CoverageGap DownIRMDIradimed4.8759 of 5 stars$49.37-1.1%$72.00+45.8%+27.1%$627.74M$73.24M32.91110Short Interest ↓News CoveragePositive NewsAVNSAvanos Medical3.1827 of 5 stars$12.88-4.0%N/A-36.1%$592.43M$687.80M37.884,040Positive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Artivion Competitors Establishment Labs Competitors National Vision Competitors AxoGen Competitors Embecta Competitors Bioventus Competitors RxSight Competitors CeriBell Competitors Iradimed Competitors Avanos Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SMTI Stock Free SMTI Stock Alerts